Cannabis

Data Suggests The Perfect CBD To THC Ratio

Published

2 years ago

August 7, 2023

admin

Researchers from the University of Colorado’s Anschutz Medical Campus analyzed the impact of cannabis flowers with almost equal ratios of THC and CBD, and its effects on subjects. The data suggests the perfect CBD to THC ratio

The study, published in the journal Addiction Biology, examined subjects who were tasked to smoke cannabis flower with various ratios, which were randomly assigned. These included 24% THC and 1% CBD, 23% CBD and 1% THC, as well as flowers that had almost equal ratios of each, 10% THC and 9% CBD. After an hour, the researchers measured their effects.

Will Congress Boost Hemp Total THC Limit To 1%? — Photo by anankkml/Getty Images

They found that the patients who smoked the THC dominant cannabis and those who smoked nearly equal ratios and those who smoked the flowers with almost equal ratios experienced similar positive benefits. The difference was that the participants who consumed samples with nearly equal ratios reported less negative side effects including paranoia and anxiety.

“This is one of the first studies to examine the differential effects of various THC and CBD ratios using cannabis flower chemovars that are widely available in state-regulated markets. The present findings suggest that CBD may be associated with an overall reduction of THC exposure and may mitigate the negative psychotomimetic effects of THC without diminishing the effects of THC that individuals report liking,” they write.

“The results of the present study suggest that participants using the THC+CBD chemovar had significantly lower plasma THC levels and reported less paranoia and anxiety as compared to participants using the THC dominant chemovar. Importantly, despite these differences, participants in both the THC+CBD and THC conditions reported similar positive subjective effects… The harm reduction implication of these findings is that cannabis chemovars containing CBD may result in less overall exposure to THC and subsequently less potential for harm, particularly with respect to the psychotomimetic effects of THC,” they concluded.

Why Ratio Matters

CBD and THC are the two primary cannabinoids in the cannabis plant. They each have their own properties; THC is the psychoactive compound that is responsible for making you feel high. The more THC a flower or product contains, the higher you will feel. But aside from just getting you high, THC is widely used for its medicinal properties such as its ability to induce appetite, treat insomnia, stop nausea, and provide relief from pain. However, the right dose is essential because too much THC can make people feel paranoid and anxious. On the other hand, CBD is non-psychoactive and is used for relaxation, insomnia, anxiety, pain, and much more.

When the two are combined in varying ratios, they enhance each other’s beneficial properties synergistically in what is known as the “entourage effect”. Aside from that, all of us have a different biological makeup which is why how you react to CBD may be different from how your friend reacts to CBD, even if you both took exactly the same dose.

It has been recognized by scientists that the ideal dose for most people who want to achieve the most therapeutic benefits is an equal ratio of each, or 1:1 THC CBD. This ratio can help you stay productive without feeling too high since CBD counteracts the highs of THC, while also offering a wide range of health benefits including pain management, anxiety reduction, and better sleep among others.

Common Ratios

When shopping around for cannabis products, those that use a combination of both cannabinoids present various ratios. Here are the most common ratios:

0:1 CBD THC: With no CBD in the product, you will be able to feel the highs of THC which many find to be uplifting and euphoric, while reducing stress. If you are one of those people who are sensitive to THC or have a low tolerance, you may be prone to anxiety and paranoia. However, many people prefer it because it provides relief from pain and inflammation while improving energy and mood.

Delta-10 THC: Is It The Future Of Cannabis? — Photo by GRAS GRÜN via Unsplash

1:0 CBD THC: A product that has no THC will not make you feel any kind of high. People who enjoy the relaxation brought about by CBD will appreciate these types of products as they can mildly sedate while still improving your mood and helping to reduce anxiety and panic attacks.

1:1 CBD THC: For people who aren’t familiar with CBD and THC, this is the recommended ratio to start with. You will be able to experience the best of both worlds, but also the presence of CBD will negate getting too high from the THC. In addition, you will be able to stay functional and productive.

1:9 or more: These are usually high-THC products, which means that you will likely experience the characteristics that are typically associated with THC. These may be beneficial for people who are suffering from severe pain, nausea, migraines, lack of appetite due to chemotherapy or radiation, and more. Just keep in mind that it also means you will get a high.

Aside from these, you will also encounter other ratios in the market such as 2:1, 3:1, or 4:1 as well as 25: 1 and others. If you aren’t sure where to start, remember that the more CBD it contains, the less THC psychoactivity you will experience. If you don’t want to get high, always opt for a product that has a higher CBD content or an equal ratio.

Talk to a budtender at your nearest dispensary to learn more about recommendations based on your personal needs. These ratios are available in many cannabis products from oils to tinctures, edibles, and so much more.

Source link

Cannabis

Cannabis Consumers Are Being Hit By The Tariffs

Published

1 day ago

April 4, 2025

admin

Tariffs are the word of the day – but marijuana consumers need to be ready to see a change also.

From apples to automobiles, hundreds of industries are trying to figure out the new tariffs. What is clear is prices are going up on a random amount of things. But, why is a surprise, is cannabis consumers are being hit by the tariffs also. Although cannabis itself cannot be imported or exported due to federal restrictions, the industry heavily relies on international suppliers for key components like vaporizer hardware, packaging, and cultivation equipment.

For instance, products sourced from China now face cumulative tariffs as high as 45%, including a 10% increase imposed in February 2025. Similarly, imports from Canada and Mexico face 25% tariffs. These measures have particularly affected items like vape cartridges, batteries, and specialized packaging materials, which are difficult to source domestically at competitive prices. As a result, many cannabis companies are passing these increased costs down the supply chain to consumer

The financial burden of these tariffs is substantial. Analysts estimate that most cannabis businesses lack the margin flexibility to absorb a 10%-15% cost increase. This has led to higher retail prices for products like pre-rolls and vaporizers, potentially pushing consumers toward cheaper, unregulated black-market alternatives. Such a shift raises concerns about product safety and could undermine the legal market’s growth.

Additionally, the tariffs have caused stock prices of major cannabis companies like Tilray Brands and Canopy Growth to decline by 5%-10%, reflecting investor concerns over profitability.Smaller businesses, already constrained by high taxes and limited banking access, are particularly vulnerable to these economic pressures.

Efforts to mitigate tariff-related expenses include exploring alternative manufacturing locations in countries like Malaysia or India. However, transitioning production is complex and time-consuming due to logistical hurdles and regulatory compliance requirements. Domestic production is another option but often comes with higher costs and limited capacity.

Packaging regulations in many states exacerbate the situation by requiring child-resistant designs, further limiting affordable domestic alternatives. Some companies are exploring sustainable packaging solutions as a long-term strategy to reduce dependence on volatile international markets.

The ongoing trade tensions show no signs of easing under Trump’s administration, leaving cannabis businesses with little choice but to adapt quickly. Strategies such as diversifying suppliers, investing in automation, and innovating with local materials may help companies weather the storm. However, without significant policy shifts or financial support mechanisms, the industry faces a challenging road ahead.

Source link

allergies

Cannabis Can Help A Sore Throat

Published

2 days ago

April 2, 2025

admin

There is a buzz about sore throats today. While they are most common in colder months, spring allergies bring the pain also. This is often due to postnasal drip, which is when mucus from the nose and sinuses drains down the back of the throat, causing irritation and a scratchy feeling. Overuse of the voice, like talking loudly or singing for long periods, can tire out and strain the muscles in your throat, causing them to feel sore. The good news is cannabis can help a sore throat.

RELATED: How Hemp Helps You Sleep

For those seeking natural alternatives to manage cold symptoms, cannabis is emerging as a promising option for throat irritation. Increasing research at medical center specifically targeting sore throats shows early insights. The data suggests cannabinoids and terpenes could offer symptom relief through their unique properties.

medical marijuana — Photo by Esther Kelleter / EyeEm/Getty Images

Cannabis contains compounds like THC and CBD, which studies indicate possess anti-inflammatory properties that may reduce throat swelling and irritation. Terpenes such as eucalyptol—found in some strains—are traditionally associated with decongestant effects, potentially easing respiratory discomfort. These components work synergistically to calm inflamed tissues, though their direct impact on sore throats requires further clinical validation.

Smoking cannabis while ill remains controversial due to potential throat irritation from heat and smoke. Instead, experts recommend gentler options:

Edibles/lozenges: THC or CBD-infused products bypass inhalation, delivering localized relief without aggravating the throat.
Cannabis tea: Warm beverages with cannabis extracts may soothe scratchy throats while providing hydration.
Tinctures: Sublingual CBD oils allow precise dosing and avoid respiratory irritation.

Beyond direct throat relief, cannabis may improve overall wellness during illness. THC’s appetite-stimulating properties can combat reduced hunger, while its relaxing effects might promote restorative sleep. CBD’s muscle-relaxing qualities could help alleviate the body aches often accompanying colds.

While preliminary findings are encouraging, users should consult healthcare providers before combining cannabis with conventional cold medications due to potential interactions. Starting with low-dose CBD products may offer benefits without psychoactive effects. As legalization expands, more targeted research is expected to clarify cannabis’s role in respiratory health.

Innovative cannabis formulations—from throat-calming lozenges to anti-inflammatory teas—are redefining how we approach minor ailments. For those navigating cold season, these plant-based solutions present a compelling fusion of traditional herbal wisdom and modern cannabinoid science

Source link

Cannabis

White House Finally Comments On Marijuana Industry

Published

3 days ago

April 1, 2025

admin

Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.

Source link